ALLIANCEBERNSTEIN L.P. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 94 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$460,000
-13.7%
8,7000.0%0.00%
Q2 2020$533,000
+20.9%
8,700
+11.5%
0.00%
Q1 2020$441,000
+9.2%
7,800
+9.9%
0.00%
Q4 2019$404,000
+6.3%
7,1000.0%0.00%
Q3 2019$380,000
+8.0%
7,100
+20.3%
0.00%
Q2 2019$352,000
-7.4%
5,900
-3.3%
0.00%
Q1 2019$380,000
+2.7%
6,1000.0%0.00%
Q4 2018$370,000
+31.7%
6,100
+27.1%
0.00%
Q3 2018$281,000
-64.6%
4,800
-71.9%
0.00%
-100.0%
Q3 2017$794,000
-31.6%
17,070
-27.1%
0.00%0.0%
Q2 2017$1,160,000
-48.1%
23,420
-42.6%
0.00%
-50.0%
Q1 2017$2,237,000
+393.8%
40,820
+401.8%
0.00%
Q4 2016$453,000
+1361.3%
8,135
+916.9%
0.00%
Q1 2015$31,000
+106.7%
800
+100.0%
0.00%
Q4 2014$15,000
+7.1%
4000.0%0.00%
Q3 2014$14,000
-36.4%
400
-50.0%
0.00%
Q2 2014$22,000
+633.3%
800
+633.9%
0.00%
Q1 2014$3,000
+50.0%
1090.0%0.00%
Q4 2013$2,0000.0%1090.0%0.00%
Q3 2013$2,000
+100.0%
109
+36.2%
0.00%
Q2 2013$1,000800.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 70,088$1,817,0001.56%
Redmile Group, LLC 271,620$7,040,0000.84%
NORTHPOINTE CAPITAL LLC 96,200$2,493,0000.25%
Ativo Capital Management LLC 14,475$375,0000.15%
TFS CAPITAL LLC 43,437$1,126,0000.07%
Hillsdale Investment Management Inc. 9,480$246,0000.07%
PARADIGM ASSET MANAGEMENT CO LLC 18,100$469,152,0000.06%
GSA CAPITAL PARTNERS LLP 33,647$872,0000.06%
RICE HALL JAMES & ASSOCIATES, LLC 22,599$586,0000.04%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 60,462$1,567,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders